$AIMD
Ainos, Inc. Stock $aimd

$aimd Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000165495422003463 Filed on March 21, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$26.40K	$594.6K	$0.00
YoY Change		3489.71%
Cost Of Revenue	$9.790K	$184.2K	$0.00
YoY Change		1533.24%
Gross Profit	$16.61K	$410.4K	$0.00
YoY Change		7663.56%
Gross Profit Margin	62.92%	69.02%
Selling, General & Admin	$178.2K	$2.357M	$440.0K
YoY Change	-59.5%	63.09%	18.92%
% of Gross Profit	1072.79%	574.38%
Research & Development	$1.274M	$1.921M	$0.00
YoY Change		493639.07%
% of Gross Profit	7669.18%	468.01%
Depreciation & Amortization		$31.40K
YoY Change		1625.0%
% of Gross Profit		7.65%
Operating Expenses	$1.452M	$4.278M	$440.0K
YoY Change	230.01%	195.89%	18.92%
Operating Profit	-$1.435M	-$3.867M	-$440.0K
YoY Change	226.23%	168.49%	18.92%
Interest Expense	-$9.330K	$11.90K	-$10.00K
YoY Change	-6.7%	11.17%
% of Operating Profit
Other Income/Expense, Net	$0.00	$0.00
YoY Change
Pretax Income	-$1.445M	-$21.24K	-$450.0K
YoY Change	221.06%	108.44%	21.62%
Income Tax
% Of Pretax Income
Net Earnings	-$1.445M	-$3.889M	-$450.0K
YoY Change	221.06%	168.07%	21.62%
Net Earnings / Revenue	-5472.61%	-654.04%
Basic Earnings Per Share
Diluted Earnings Per Share	-$96.18K	-$515.2K	-$0.16
COMMON SHARES
Basic Shares Outstanding	142.4M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.752M	$1.750M	$20.00K
YoY Change	8657.5%	8650.0%	-95.12%
Cash & Equivalents	$1.751M	$1.750M	$22.25K
Short-Term Investments
Other Short-Term Assets	$466.2K	$470.0K	$50.00K
YoY Change	832.4%	840.0%	66.67%
Inventory	$183.4K		$0.00
Prepaid Expenses
Receivables	$0.00		$0.00
Other Receivables
Total Short-Term Assets	$2.218M	$2.220M	$76.41K
YoY Change	2802.25%	2675.0%	-82.84%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.188M	$1.190M	$3.249K
YoY Change	36455.92%		-35.89%
Goodwill
YoY Change
Intangibles	$37.33M		$180.6K
YoY Change	20566.34%
Long-Term Investments
YoY Change
Other Assets	$87.57K	$90.00K	$54.17K
YoY Change	61.67%
Total Long-Term Assets	$38.60M	$38.60M	$183.9K
YoY Change	20894.72%	21344.44%	21.51%
TOTAL ASSETS
Total Short-Term Assets	$2.218M	$2.220M	$76.41K
Total Long-Term Assets	$38.60M	$38.60M	$183.9K
Total Assets	$40.82M	$40.82M	$260.3K
YoY Change	15583.34%	15600.0%	-56.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.005M	$1.000M	$150.0K
YoY Change	569.91%	566.67%	-28.57%
Accrued Expenses	$28.67K	$1.000M	$24.20K
YoY Change	18.5%
Deferred Revenue
YoY Change
Short-Term Debt	$3.590M	$3.590M	$950.0K
YoY Change	277.89%	277.89%	115.91%
Long-Term Debt Due	$3.380M	$3.380M
YoY Change
Total Short-Term Liabilities	$30.59M	$30.59M	$1.099M
YoY Change	2684.97%	2680.91%	45.83%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$30.26K	$30.00K
YoY Change
Total Long-Term Liabilities	$30.26K	$30.00K	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$30.59M	$30.59M	$1.099M
Total Long-Term Liabilities	$30.26K	$30.00K	$0.00
Total Liabilities	$30.63M	$30.63M	$1.099M
YoY Change	2687.72%	2684.55%	45.83%
SHAREHOLDERS EQUITY
Retained Earnings	-$10.11M		-$6.220M
YoY Change	62.52%		30.41%
Common Stock	$1.444M		$420.7K
YoY Change	243.22%		3.83%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$10.20M	$10.20M	-$838.3K
YoY Change
Total Liabilities & Shareholders Equity	$40.82M	$40.82M	$260.3K
YoY Change	15583.34%	15600.0%	-56.37%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	-$1.445M	-$3.889M	-$450.0K
YoY Change	221.06%	168.07%	21.62%
Depreciation, Depletion And Amortization		$31.40K
YoY Change		1625.0%
Cash From Operating Activities	-$680.8K	-$1.250M	-$90.00K
YoY Change	656.48%	150.22%	-30.77%
INVESTING ACTIVITIES
Capital Expenditures	-$143.8K	$143.8K	$10.00K
YoY Change	-1537.9%		0.0%
Acquisitions
YoY Change
Other Investing Activities	$6.610K	-$40.00K
YoY Change
Cash From Investing Activities	-$137.2K	-$180.5K	-$10.00K
YoY Change	1271.8%	2392.3%	0.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$46.00M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.864M	$3.154M	30.00K
YoY Change	6114.13%	2528.64%	-50.0%
NET CHANGE
Cash From Operating Activities	-680.8K	-$1.250M	-90.00K
Cash From Investing Activities	-137.2K	-$180.5K	-10.00K
Cash From Financing Activities	1.864M	$3.154M	30.00K
Net Change In Cash	1.046M	$1.724M	-70.00K
YoY Change	-1594.61%	-545.68%	-12.5%
FREE CASH FLOW
Cash From Operating Activities	-$680.8K	-$1.250M	-$90.00K
Capital Expenditures	-$143.8K	$143.8K	$10.00K
Free Cash Flow	-$537.0K	-$1.394M	-$100.0K
YoY Change	437.04%	179.0%	-28.57%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Auditor Firm AuditorFirmId	6686
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	466198	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	54168	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	2217697	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	76413	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	37329191	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	180628	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1187702	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3249	USD
CY2021Q4	us-gaap	Other Assets OtherAssets	87571	USD
CY2020Q4	us-gaap	Other Assets OtherAssets	0	USD
CY2021Q4	us-gaap	Assets Assets	40822161	USD
CY2020Q4	us-gaap	Assets Assets	260290	USD
CY2021Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	3376526	USD
CY2020Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	734991	USD
CY2021Q4	us-gaap	Notes Payable NotesPayable	213405	USD
CY2020Q4	us-gaap	Notes Payable NotesPayable	218010	USD
CY2021Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	1004868	USD
CY2020Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	145567	USD
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	26000000	USD
CY2020Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	0	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	30594799	USD
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	30255	USD
CY2020Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	0	USD
CY2021Q4	us-gaap	Liabilities Liabilities	30625054	USD
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	144379308	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	42066172	shares
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	1443793	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	420662	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	18856430	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4961315	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	180628	USD
CY2020	us-gaap	Revenues Revenues	16563	USD
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	184181	USD
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	11277	USD
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2357163	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-10108916	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6220255	USD
CY2021Q4	aimd	Translation Adjustment Liability TranslationAdjustmentLiability	5800	USD
CY2020Q4	aimd	Translation Adjustment Liability TranslationAdjustmentLiability	0	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	10197107	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-838278	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	40822161	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	260290	USD
CY2021	us-gaap	Revenues Revenues	594563	USD
CY2021	us-gaap	Gross Profit GrossProfit	410382	USD
CY2020	us-gaap	Gross Profit GrossProfit	5286	USD
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1920645	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	389	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10188	USD
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1445332	USD
CY2021	us-gaap	Operating Expenses OperatingExpenses	4277808	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	1445721	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-3867426	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-1440435	USD
CY2021	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	18689	USD
CY2020	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	10185	USD
CY2021	aimd	Other Losses OtherLosses	-2547	USD
CY2020	aimd	Other Losses OtherLosses	-3	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-21236	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-3888661	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-1450623	USD
CY2021	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.03
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.04
CY2021	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	113270245	shares
CY2020	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	40730934	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-838278	USD
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	476329	USD
CY2021	aimd	Issuance Of Common Stock For Intangible Assets Amount IssuanceOfCommonStockForIntangibleAssetsAmount	20000000	USD
CY2021	aimd	Issuance Of Stock For Compensation Amount IssuanceOfStockForCompensationAmount	160978	USD
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	64752	USD
CY2021	us-gaap	Dividends Share Based Compensation DividendsShareBasedCompensation	10683	USD
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	5773130	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-3888661	USD
CY2021	aimd	Translation Adjustment TranslationAdjustment	5800	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	10197107	USD
CY2020	aimd	Issuance Of Stock For Compensation Amount IssuanceOfStockForCompensationAmount	294690	USD
CY2020	aimd	Issuance Of Stock For Cash Amount IssuanceOfStockForCashAmount	100000	USD
CY2020	us-gaap	Dividends Share Based Compensation DividendsShareBasedCompensation	374337	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-1450623	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-3888661	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-1450623	USD
CY2021	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	2044447	USD
CY2020	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	14698	USD
CY2021	aimd	Allocated Share Based Compensation Expenses AllocatedShareBasedCompensationExpenses	-10683	USD
CY2020	aimd	Allocated Share Based Compensation Expenses AllocatedShareBasedCompensationExpenses	374337	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	160978	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	150440	USD
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-2223	USD
CY2020	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-3024	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1107	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	794174	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	429510	USD
CY2021	aimd	Contract Liabilities ContractLiabilities	59575	USD
CY2020	aimd	Contract Liabilities ContractLiabilities	0	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1249977	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-499551	USD
CY2021	aimd	Patent Purchases PatentPurchases	0	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	143792	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	USD
CY2021	aimd	Increase In Refundable Deposits And Others IncreaseInRefundableDepositsAndOthers	36725	USD
CY2020	aimd	Increase In Refundable Deposits And Others IncreaseInRefundableDepositsAndOthers	0	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-180517	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7243	USD
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-size:10pt;font-family:times new roman;margin:0px">Financial instruments that potentially subject the Company to significant concentration of credit risk consist principally of cash. The Company has cash balances in a single U.S. financial institution which, from time to time, could exceed the federally insured limit of $250,000. The Company maintains multiple accounts in its Taiwan Branch office which help to mitigate risk. Our bank deposits in Taiwan are insured by the Central Deposit Insurance Corp. (“CDIC”) with an insured limit of NT$3,000,000 per account.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">No loss has been incurred related to the aforementioned concentration of cash.</p>
CY2021	aimd	Exceed Federally Insured Limit ExceedFederallyInsuredLimit	250000	USD
CY2021	aimd	Insured Limit Per Account InsuredLimitPerAccount	3000000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1218736	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	107549	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	31034	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	104300	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1187702	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3249	USD
CY2021	aimd	Acquisition Of Intangible Assets And Equipment AcquisitionOfIntangibleAssetsAndEquipment	40226870	USD
CY2020	aimd	Acquisition Of Intangible Assets And Equipment AcquisitionOfIntangibleAssetsAndEquipment	0	USD
CY2021	aimd	Decrease Of Additional Paid In Capital DecreaseOfAdditionalPaidInCapital	5773130	USD
CY2020	aimd	Decrease Of Additional Paid In Capital DecreaseOfAdditionalPaidInCapital	0	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	39371317	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	245898	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2042126	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	65270	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	37329191	USD
CY2021	aimd	Proceeds From Convertible Note Payable Related Party ProceedsFromConvertibleNotePayableRelatedParty	-3106025	USD
CY2020	aimd	Proceeds From Convertible Note Payable Related Party ProceedsFromConvertibleNotePayableRelatedParty	-120000	USD
CY2021	aimd	Payments Of Other Note Payable PaymentsOfOtherNotePayable	4605	USD
CY2020	aimd	Payments Of Other Note Payable PaymentsOfOtherNotePayable	0	USD
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	64752	USD
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2021	aimd	Payments Of Lease Liabilities PaymentsOfLeaseLiabilities	11799	USD
CY2020	aimd	Payments Of Lease Liabilities PaymentsOfLeaseLiabilities	0	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3154373	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	120000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1723879	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-386794	USD
CY2021	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	5375	USD
CY2020	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	0	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22245	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	409039	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1751499	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	19380	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	855	USD
CY2021	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	0	USD
CY2020	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	100000	USD
CY2021	aimd	Stock Issued For Patent Cost And Accrued Liabilities StockIssuedForPatentCostAndAccruedLiabilities	0	USD
CY2020	aimd	Stock Issued For Patent Cost And Accrued Liabilities StockIssuedForPatentCostAndAccruedLiabilities	144250	USD
CY2021	aimd	Conversion Of Convertible Notes And Accrued Interest Into Common Stock ConversionOfConvertibleNotesAndAccruedInterestIntoCommonStock	476329	USD
CY2020	aimd	Conversion Of Convertible Notes And Accrued Interest Into Common Stock ConversionOfConvertibleNotesAndAccruedInterestIntoCommonStock	0	USD
CY2021	aimd	Rou Leased Assets RouLeasedAssets	62903	USD
CY2020	aimd	Rou Leased Assets RouLeasedAssets	0	USD
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	46000000	USD
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2021	aimd	Recurring Losses RecurringLosses	10300000	USD
CY2021	us-gaap	Depreciation Depreciation	31395	USD
CY2020	us-gaap	Depreciation Depreciation	1820	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1187702	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3249	USD
CY2021Q4	aimd	Acquired Of Machinery And Equipment From Ainos Ky Pursuant AcquiredOfMachineryAndEquipmentFromAinosKyPursuant	944152	USD
CY2020	aimd	Total Convertible And Nonconvertible TotalConvertibleAndNonconvertible	953001	USD
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2000302	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	12878	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	4522141	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	4522141	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	4534493	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	4522141	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	4521973	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	14706301	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	37329191	USD
CY2021	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	3589931	USD
CY2020	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	953001	USD
CY2021	us-gaap	Increase Decrease In Notes Payable Related Parties IncreaseDecreaseInNotesPayableRelatedParties	3505931	USD
CY2020	us-gaap	Increase Decrease In Notes Payable Related Parties IncreaseDecreaseInNotesPayableRelatedParties	805001	USD
CY2021	aimd	Total Convertible And Nonconvertibleaddition TotalConvertibleAndNonconvertibleaddition	3251420	USD
CY2021	aimd	Total Convertible And Nonconvertiblepayment TotalConvertibleAndNonconvertiblepayment	614490	USD
CY2021	aimd	Total Convertible And Nonconvertible TotalConvertibleAndNonconvertible	3589931	USD
CY2021Q4	aimd	Total Convertible And Nonconvertiblepaymentaccrued TotalConvertibleAndNonconvertiblepaymentaccrued	28673	USD
CY2021Q4	aimd	Total Principal And Accrued Interest Amount TotalPrincipalAndAccruedInterestAmount	372988	USD
CY2021Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.25
CY2021	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	150000	USD
CY2021Q3	aimd	Interest Waived InterestWaived	45875	USD
CY2021	us-gaap	Interest Expense InterestExpense	21727	USD
CY2020	us-gaap	Interest Expense InterestExpense	10702	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	28673	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	24196	USD
CY2021Q4	aimd	Capital Stock Holding Percentage CapitalStockHoldingPercentage	0.05	pure
CY2021Q4	aimd	Outstanding Capital Stock Percentage Rate OutstandingCapitalStockPercentageRate	0.05	pure
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	100000000	shares
CY2021Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.20
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2021Q2	us-gaap	Equity Method Investment Ownership Percentage EquityMethodInvestmentOwnershipPercentage	0.7030	pure
CY2021Q4	us-gaap	Notes Payable Related Parties Current And Noncurrent NotesPayableRelatedPartiesCurrentAndNoncurrent	3505931	USD
CY2021Q2	us-gaap	Notes Payable Related Parties Current And Noncurrent NotesPayableRelatedPartiesCurrentAndNoncurrent	805001	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	183444	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	0	USD
CY2021	us-gaap	Development Costs DevelopmentCosts	205883	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	65156	USD
CY2020	us-gaap	Development Costs DevelopmentCosts	0	USD
CY2021	aimd	Covid Ninteen Antigen Rapid Test Kits Amount CovidNinteenAntigenRapidTestKitsAmount	209468	USD
CY2020	aimd	Covid Ninteen Antigen Rapid Test Kits Amount CovidNinteenAntigenRapidTestKitsAmount	0	USD
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P9Y3M29D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	2.76	pure
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2021	aimd	Options Exercisable Term Period OptionsExercisableTermPeriod	P10Y
CY2021	aimd	Options To Acquire Shares Of Common Stock OptionsToAcquireSharesOfCommonStock	550000	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.38
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0	USD
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue	0
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.38
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.38
CY2021	aimd	Weighted Average Remaining Contactual Term Granted WeightedAverageRemainingContactualTermGranted	P10Y
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.38
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0	USD
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.38
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue	0
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.38
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y3M29D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	0.38
CY2021	aimd	Discount Percentage DiscountPercentage	0.0296	pure
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	953604	USD
CY2021	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y9M
CY2021	us-gaap	Employee Stock Ownership Plan Esop Plan Description EmployeeStockOwnershipPlanESOPPlanDescription	The aggregate number of shares which may be issued pursuant to awards under the Plan is 20,000,000 shares of Common Stock (the “Plan Share Reserve”), subject to adjustments as provided in the Plan. The number of shares underlying any award granted under 2018 ESOP or 2018 NQSOP (the “Prior Plans”) that expires, terminates or is canceled or forfeited for any reason whatsoever under the terms of the Prior Plans, will increase the Plan Share Reserve. Each Award granted under the Plan will reduce the Plan Share Reserve by the number of shares underlying the award. No more than 10,000,000 shares may be issued in the aggregate pursuant to the exercise of incentive stock options granted under the Plan. The maximum number of shares subject to awards granted during a single fiscal year to any non-employee director, taken together with any cash fees paid to such director during the fiscal year, will not exceed $600,000 in total value (calculating the value of any such awards based on their grant date fair value for financial reporting purposes)
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-816000	USD
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-305000	USD
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	0	USD
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	1000	USD
CY2021	aimd	Temporary Differences TemporaryDifferences	206000	USD
CY2020	aimd	Temporary Differences TemporaryDifferences	79000	USD
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	610000	USD
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	225000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	4357000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	4328270	USD
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	248000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	217000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	4605000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	4545270	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	USD
CY2021Q4	aimd	Net Deferred Tax Assets NetDeferredTaxAssets	4605000	USD
CY2020Q4	aimd	Net Deferred Tax Assets NetDeferredTaxAssets	4545270	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4605000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4545270	USD
CY2021Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	20747517	USD
CY2021Q4	aimd	Office Space OfficeSpace	1250	sqft
CY2021Q4	aimd	Product Development Facility Area ProductDevelopmentFacilityArea	8517	sqft
CY2021Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	670000	USD
CY2021Q4	aimd	Outstanding Contract Amount For Construction In Progress OutstandingContractAmountForConstructionInProgress	464000	USD
CY2021Q2	us-gaap	Salaries And Wages SalariesAndWages	250000	USD
CY2021Q2	aimd	Monthly Salary Equivalent To Taiwan Dollors MonthlySalaryEquivalentToTaiwanDollors	8929	USD
CY2021Q2	aimd	Annual Compensation In The Form Of Cash Percentage Range AnnualCompensationInTheFormOfCashPercentageRange	10-30
CY2021Q3	us-gaap	Salaries And Wages SalariesAndWages	230000	USD
CY2021Q3	aimd	Monthly Salary Equivalent To Taiwan Dollors MonthlySalaryEquivalentToTaiwanDollors	8214	USD
CY2021Q3	aimd	Annual Compensation In The Form Of Cash Percentage Range AnnualCompensationInTheFormOfCashPercentageRange	10-30
CY2021Q3	us-gaap	Salaries And Wages SalariesAndWages	12000	USD
CY2021Q3	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	500000	shares
CY2021Q3	us-gaap	Common Stock Dividends Shares CommonStockDividendsShares	10000	shares
CY2020Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	452617	shares
CY2020Q1	aimd	Non Convertible Note Issued Principal Amount NonConvertibleNoteIssuedPrincipalAmount	84000	USD
CY2021Q4	us-gaap	Principal Amount Outstanding On Loans Securitized PrincipalAmountOutstandingOnLoansSecuritized	103342	USD
CY2021Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	413368	shares
CY2021Q4	us-gaap	Preferred Stock Convertible Conversion Price PreferredStockConvertibleConversionPrice	0.25
CY2021	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	240000	USD
CY2021	aimd	Shares Payable Quarterly Based On The Average Share Price SharesPayableQuarterlyBasedOnTheAverageSharePrice	100000	USD
CY2021Q1	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	70000	USD
CY2021Q1	aimd	Shares Payable Quarterly Based On The Average Share Price SharesPayableQuarterlyBasedOnTheAverageSharePrice	1000	USD
CY2021Q4	aimd	Unpaid Principal Amount UnpaidPrincipalAmount	3000000	USD
CY2021Q4	aimd	Accrued Interest AccruedInterest	9507	USD

Files In Submission

Name	View Source	Status
0001654954-22-003463-index-headers.html	Edgar Link	pending
0001654954-22-003463-index.html	Edgar Link	pending
0001654954-22-003463.txt	Edgar Link	pending
0001654954-22-003463-xbrl.zip	Edgar Link	pending
aimd-20211231.xsd	Edgar Link	pending
aimd-20211231_cal.xml	Edgar Link	unprocessable
aimd-20211231_def.xml	Edgar Link	unprocessable
aimd-20211231_lab.xml	Edgar Link	unprocessable
aimd-20211231_pre.xml	Edgar Link	unprocessable
aimd_10k.htm	Edgar Link	pending
aimd_10k_htm.xml	Edgar Link	completed
aimd_ex10iii.htm	Edgar Link	pending
aimd_ex10vi.htm	Edgar Link	pending
aimd_ex10viimg1.jpg	Edgar Link	pending
aimd_ex10viimg2.jpg	Edgar Link	pending
aimd_ex10xii.htm	Edgar Link	pending
aimd_ex10xiii.htm	Edgar Link	pending
aimd_ex10xiv.htm	Edgar Link	pending
amid_ex231.htm	Edgar Link	pending
amid_ex311.htm	Edgar Link	pending
amid_ex312.htm	Edgar Link	pending
amid_ex321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AIMD
Ainos, Inc. Stock $aimd

2021 Q4 Form 10-K Financial Statement

#000165495422003463 Filed on March 21, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AIMD Ainos, Inc. Stock $aimd

2021 Q4 Form 10-K Financial Statement

#000165495422003463 Filed on March 21, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AIMD
Ainos, Inc. Stock $aimd